Products 875320-29-9
CAS 875320-29-9 appears in our catalog under these names: JNJ-26481585, Quisinostat, JNJ–26481585, JNJ-26481585-d3, quisinostat, 98%, 98%. Offered by: TRC, TargetMol, GLPBio, Biosynth, Chemat. Available pack sizes: 100mg, 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 1000mg.
Quisinostat is a member of the class of methylindoles that is 1H-indole substituted by methyl and [({1-[5-(hydroxycarbamoyl)pyrimidin-2-yl]piperidin-4-yl}methyl)amino]methyl groups at positions 1 and 3, respectively. It is an orally bioavailable pan-HDAC inhibitor that exhibits antineoplastic activity. It has a role as a radiosensitizing agent, an autophagy inducer, an antineoplastic agent, an antimalarial, a bone density conservation agent and an EC 3.5.1.98 (histone deacetylase) inhibitor. It is a hydroxamic acid, a member of piperidines, a methylindole, a member of pyrimidines and a secondary amino compound.
Source: ChEBI
| Molecular formula | C21H26N6O2 |
|---|---|
| Molecular weight | 394.5 g/mol |
| IUPAC name | N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide |
| InChIKey | PAWIYAYFNXQGAP-UHFFFAOYSA-N |
| SMILES | CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO |
Computed by PubChem (NCBI)